The implementation of medical marijuana programs provides countless benefits for patients suffering from a wide array of illnesses, but with legalization of such a product that spans across agricultural, food and beverage, and medicinal industries, there comes the need to create regulations that promote the health and safety of consumers. One issue the cannabis industry has struggled with is the creation of quality controlled lab testing standards that search for potency and contamination within products. There is no standard for lab testing cannabis that spans across one entire state, let alone across state lines or nationwide due to FDA restrictions. Because of this, testing results vary between labs making it hard for patients to know whether or not the cannabinoid content of their product is ideal for their symptoms. Additionally, contaminants that slip by unnoticed could interfere with the medical benefits of cannabis and even cause serious health effects for patients who are already immunocompromised.
The industry currently lacks in standard lab testing methods, but there are already companies that have developed analytical tools and instruments for other industries, like food safety and clinical laboratories, whose lab testing methods could and should be introduced and adapted to the cannabis industry. It is especially important that medical cannabis is held to higher standards of testing due to the fact it is a medicinal product used to heal those who do not have strong immune systems. Companies need to go above and beyond meeting the requirements of unregulated testing to ensure patients safely get access to the help they need. One such organization, CANNCON Inc., is working towards the future of analytical testing and quality control for cannabis, as well as promoting personalized cannabis treatments tailored to patients' unique genomes and metabolomes.
This information has been provided by Medical Jane and approved by our Chief Medical Officer.